| 4.11 0 (0%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5.06 | 1-year : | 5.51 |
| Resists | First : | 4.33 | Second : | 4.72 |
| Pivot price | 4.05  |
|||
| Supports | First : | 3.71 | Second : | 3.08 |
| MAs | MA(5) : | 4.07 |
MA(20) : | 4.15 |
| MA(100) : | 4.15 |
MA(250) : | 4.47 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 50.4 |
D(3) : | 43.1 |
| RSI | RSI(14): 50.1 | |||
| 52-week | High : | 6.6 | Low : | 3.2 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ KRMD ] has closed below upper band by 39.1%. Bollinger Bands are 0.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.2 - 4.23 | 4.23 - 4.25 |
| Low: | 3.91 - 3.93 | 3.93 - 3.95 |
| Close: | 4.07 - 4.11 | 4.11 - 4.15 |
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Wed, 29 Jul 2026
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference - BioSpace
Wed, 29 Jul 2026
BlackRock (NYSE: BLK) discloses 5.6% beneficial stake in KORU Medical Systems (KRMD) - Stock Titan
Wed, 29 Jul 2026
KORU Medical Systems Inc (KRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wed, 29 Jul 2026
KORU Medical Systems, Inc. Revenue Breakdown – NASDAQ:KRMD - tradingview.com
Mon, 27 Jul 2026
First Light Asset Management LLC Lowers Position in KORU Medical Systems, Inc. $KRMD - MarketBeat
Wed, 15 Jul 2026
KORU Medical Sets Date for Its Next Financial Results Update - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 8 (%) |
| Held by Institutions | 57 (%) |
| Shares Short | 807 (K) |
| Shares Short P.Month | 744 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.37 |
| Profit Margin | -5.3 % |
| Operating Margin | -7.4 % |
| Return on Assets (ttm) | -5.9 % |
| Return on Equity (ttm) | -13.7 % |
| Qtrly Rev. Growth | 22.1 % |
| Gross Profit (p.s.) | 0.58 |
| Sales Per Share | 0.94 |
| EBITDA (p.s.) | -0.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -82.21 |
| PEG Ratio | 0 |
| Price to Book value | 11.1 |
| Price to Sales | 4.36 |
| Price to Cash Flow | 264.19 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|